Compositions and methods for prevention and treatment of pulmonary hypertension

Details for Australian Patent Application No. 2011210352 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Radikal Therapeutics Inc.

Inventors Salzman, Andrew Lurie; Magdassi, Shlomo; Margulis-Goshen, Katrin

Agent FB Rice

Pub. Number AU-A-2011210352

PCT Pub. Number WO2011/092690

Priority 61/334,211 13.05.10 US; 61/298,224 26.01.10 US

Filing date 26 January 2011

Wipo publication date 4 August 2011

International Classifications

A61K 31/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 9/51 Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/445 - Non-condensed piperidines, e.g. piperocaine

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 9/12 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/092690 Priority application(s): WO2011/092690

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011210356-Method for improved fibrin sealing

2011210351-Colonic cleansing device